Deep Dive: GSK's Use of Artificial Intelligence to Revolutionize R&D in FTSE 100
Friday, 13 February 2026, 06:51
GSK and Artificial Intelligence
Deep dive into GSK's innovative use of artificial intelligence through their proprietary platform, Cogito Forge. Unlike standard AI models, it utilizes agents that debate potential targets and simulate results, promising to significantly alter research and development strategies within the FTSE 100 environment.
How Cogito Forge Works
- Agent Collaboration: Each agent proposes a target and the others assess its viability.
- Enhanced Simulations: Rapid simulations can lead to faster decision-making.
- Stock Impact: By improving R&D efficiency, GSK could enhance its position within the stocks & shares market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.